SOPHiA GENETICS (SOPH) Share-based Compensation (2020 - 2026)

SOPHiA GENETICS has disclosed Share-based Compensation across 7 years of filings, most recently posting $4.5 million for Q2 2026.

• In Q2 2026, Share-based Compensation rose 3.12% year-over-year to $4.5 million; the TTM figure through Jun 2026 stood at $15.8 million (down 6.3% YoY), while the FY2025 annual figure was $16.2 million, down 1.72% from the prior year.
• Share-based Compensation came in at $4.5 million for Q2 2026 at SOPHiA GENETICS, up from $3.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.1 million in Q4 2024 to a low of $2.4 million in Q1 2023.
• Average Share-based Compensation over 5 years is $3.9 million, with a median of $3.9 million recorded in 2022.
• Year-over-year, Share-based Compensation surged 443.19% in 2022 and retreated 29.99% in 2023.
• Over 5 years, Share-based Compensation stood at $2.6 million in 2022, then soared by 62.02% to $4.2 million in 2023, then gained by 20.73% to $5.1 million in 2024, then declined by 23.83% to $3.9 million in 2025, then increased by 16.13% to $4.5 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $4.5 million in Q2 2026, $3.3 million in Q1 2026, and $3.9 million in Q4 2025.